ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165
- Status
- COMPLETED
- Phase
- PHASE2
Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM)
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2